About Sernova (CVE:SVA)
Sernova Corp. is a development-stage regenerative medicine company. The Company is engaged in the development of its Cell Pouch and associated technologies, including therapeutic cells for the treatment of chronic diseases and local immune protection technologies. It is focused on developing a treatment for insulin-dependent human diabetes and other metabolic, blood and neurological diseases with therapeutic cells placed into its implanted and prevascularized medical device (the Cell Pouch), protected from immune system attack. The Cell Pouch is designed to create a microvessel rich, tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the treatment of chronic diseases, such as diabetes and thyroid disease. Its lead program is the clinical development of the Cell Pouch for treatment of patients with insulin dependent diabetes. It is also evaluating Cell Pouch for the treatment of patients with hemophilia A.
Industry, Sector and Symbol
Industry Medical Laboratories & Research
Trailing P/E Ratio-41
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-58.97%
Return on Assets-49.67%
Sernova (CVE:SVA) Frequently Asked Questions
What is Sernova's stock symbol?
Sernova trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SVA."
When will Sernova make its next earnings announcement?
Who are some of Sernova's key competitors?
Some companies that are related to Sernova include Trinity Biotech (TRIB), Diurnal Group (DNL), Bioventix (BVXP), Advaxis (ADXS), Ekf Diagnostics (EKF), ConforMIS (CFMS), Matinas BioPharma (MTNB), aTyr Pharma (LIFE), Second Sight Medical Products (EYES), Sinclair Pharma (SPH), Nobilis Health (HLTH), Verona Pharma (VRP), Motif Bio (MTFB), Complete Genomics (GNOM), Tissue Regenix Group (TRX), Viveve Medical (VIVE), IRIDEX (IRIX) and Shield Therapeutics (STX).
Who are Sernova's key executives?
Sernova's management team includes the folowing people:
- Frank A. Holler, Chairman of the Board (Age 57)
- Philip Toleikis, President, Chief Executive Officer
- Scott Langille, Chief Financial Officer (Age 59)
- James T. Parsons, Director
- Bruce Weber, Director
- Jeffrey A. Bacha, Independent Director (Age 48)
How do I buy Sernova stock?
Shares of Sernova and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Sernova's stock price today?
One share of Sernova stock can currently be purchased for approximately C$0.41.
How big of a company is Sernova?
Sernova has a market capitalization of C$65.37 million.
How can I contact Sernova?
Sernova's mailing address is 700 Collip Cir Suite 114, LONDON, ON N6G 4X8, Canada. The company can be reached via phone at +1-519-8585184.
MarketBeat Community Rating for Sernova (SVA)MarketBeat's community ratings are surveys of what our community members think about Sernova and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Sernova (CVE:SVA) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Sernova (CVE:SVA) Earnings History and Estimates Chart
Sernova (CVE SVA) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/5/2018|| || || || || || || || |
Sernova (CVE:SVA) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Sernova (CVE:SVA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Sernova (CVE SVA)
No insider trades for this company have been tracked by MarketBeat.com
Sernova (CVE SVA) News Headlines
Sernova (CVE:SVA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Sernova (CVE SVA) Stock Chart for Tuesday, January, 16, 2018